相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Anna D. Wagner et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)
Manish R. Sharma et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
The minimum clinically important difference: which direction to take
T. H. P. Draak et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
Alexandre Chan et al.
SUPPORTIVE CARE IN CANCER (2019)
Concerns regarding use of patient-reported outcomes in biomarker studies of chemotherapy-induced peripheral neuropathy
Daniel L. Hertz
PHARMACOGENOMICS JOURNAL (2019)
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
Hanna Bandos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
Hanna Bandos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
Ethan Basch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials
Jennifer Le-Rademacher et al.
SUPPORTIVE CARE IN CANCER (2017)
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
Ethan Basch et al.
JAMA ONCOLOGY (2017)
The past and future of 'reported outcomes' in studies on chemotherapy neuropathy
A. S. Beutler et al.
ANNALS OF ONCOLOGY (2017)
Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
Massimo Di Maio et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
Roser Velasco et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer
Katsumasa Kuroi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
TJ Postma et al.
EUROPEAN JOURNAL OF CANCER (2005)
分享论文
